Longitudinal 10-year prospective survey of fungaemia in Slovak Republic:: trends in etiology in 310 episodes

被引:35
作者
Krcmery, V [1 ]
Kovacicová, G [1 ]
机构
[1] Univ Trnava, Dept Med, Trnava 91700, Slovakia
关键词
D O I
10.1016/S0732-8893(99)00096-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A 10-year prospective survey of fungaemia in the Slovak Republic, involving 31 microbiology laboratories and 71 hospitals, was conducted from 1989-1998 (10 years): 310 fungaemias were analyzed for etiology, clinical characteristics, therapy, and outcome. C. albicans was responsible for 191 (61.6%) fungaemias, non-albicans Candida spp. (NAC) for 97 (31.3%), non-Candida yeasts for 18 (5.8%) and moulds (Fusarium spp.) for four fungaemias. The most frequent NAC isolated from blood cultures were C. parapsilosis-30 (9.7%), C. krusei-18 (5.8%), C. tropicalis-14 (4.5%), and C. glabrata-10 (3.2%). Secular trends in etiology showed a sustaining decrease of C. albicans (from 100% in 1989 to 50.7% in 1998) and increase of NAC (from 0% in 1989-1990 to 46.3% in 1998). Non-Candida yeasts and moulds showed a stable proportion during the investigated period. There were statistically significant differences in etiology of fungaemia various subgroups of patients: non-albicans Candida spp. was significantly more frequent observed among subgroups of patients with pancreatitis and coma (53.3% vs. 31.3%, p less than or equal to 0.02) and less frequently in the subgroup of neonates (15.0% vs. 31.3%, p less than or equal to 0.006). Vice versa, C. albicans appeared more frequently in neonates (85%). (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 42 条
  • [1] A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients
    AbeleHorn, M
    Kopp, A
    Sternberg, U
    Ohly, A
    Dauber, A
    Russwurm, W
    Buchinger, W
    Nagengast, O
    Emmerling, P
    [J]. INFECTION, 1996, 24 (06) : 426 - 432
  • [2] The epidemiology of hematogenous candidiasis caused by different Candida species
    AbiSaid, D
    Anaissie, E
    Uzun, O
    Raad, I
    Pinzcowski, H
    Vartivarian, S
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) : 1122 - 1128
  • [3] DISSEMINATED TRICHOSPORONOSIS - MEETING THE CHALLENGE
    ANAISSIE, E
    BODEY, GP
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (09) : 711 - 713
  • [4] BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
  • [5] INVASIVE FUNGAL DISEASE IN ADULTS UNDERGOING REMISSION-INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA - THE PATHOGENETIC ROLE OF THE ANTILEUKEMIC REGIMEN
    BOW, EJ
    LOEWEN, R
    CHEANG, MS
    SCHACTER, B
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 (02) : 361 - 369
  • [6] BOW EJ, 1997, CLIN INFECT DIS, V24, P394
  • [7] DEMITROVICOVA A, 1997, ANTIINFECT DRUGS CHE, V3, P26
  • [8] SHOULD ALL PATIENTS WITH CANDIDEMIA BE TREATED WITH ANTIFUNGAL AGENTS
    EDWARDS, JE
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) : 422 - 423
  • [9] CONTROLLED-STUDY OF FLUCONAZOLE IN THE PREVENTION OF FUNGAL-INFECTIONS IN NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND BONE-MARROW TRANSPLANT RECIPIENTS
    ELLIS, ME
    CLINK, H
    ERNST, P
    HALIM, MA
    PADMOS, A
    SPENCE, D
    KALIN, M
    QADRI, SMH
    BURNIE, J
    GREER, W
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (01) : 3 - 11
  • [10] FOLTAN V, 1999, STATE I DRUG CONTROL, P25